This study also allowed for the association of aminopeptidase N (ANPEP) and transforming growth factor-beta-induced protein ig-h3 (TGFB1) with NAFLD and cirrhosis. The gene discussed is ANPEP; the disease is metabolic dysfunction-associated steatotic liver disease.